Cross-national price differences for pharmaceuticals: how large, and why?
- 1 March 2000
- journal article
- research article
- Published by Elsevier BV in Journal of Health Economics
- Vol. 19 (2), 159-195
- https://doi.org/10.1016/s0167-6296(99)00039-9
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- National Health Expenditures In 1997: More Slow GrowthHealth Affairs, 1998
- Why Medical Care Costs in Japan Have Increased Despite Declining Prices for PharmaceuticalsPharmacoEconomics, 1998
- Price Discrimination for Pharmaceuticals: Welfare Effects in the US and the EUInternational Journal of the Economics of Business, 1997
- Characteristics of demand for pharmaceutical products: an examination of four cephalosporins.The RAND Journal of Economics, 1997
- Auditing the Producer Price Index: Micro Evidence from Prescription Pharmaceutical PreparationsJournal of Business & Economic Statistics, 1993
- Brand Loyalty, Entry, and Price Competition in Pharmaceuticals after the 1984 Drug ActThe Journal of Law and Economics, 1992
- Europe After 1992: Implications For PharmaceuticalsHealth Affairs, 1991
- The demand for prescription drugs as a function of cost-sharingSocial Science & Medicine, 1985
- The Gerschenkron Effect: A Re-ExaminationThe Review of Economics and Statistics, 1970
- The Soviet Indices of Industrial ProductionThe Review of Economics and Statistics, 1947